REFERENCES
- Aksoy, S., Ariturk, S., Armstrong, M. Y. K., Chang, K. P., Dortbudak, Z., Gottlieb, M., Ozcel, M. A., Richards, F. F. & Western, K. (1995). The GAP project in southeastern Turkey: the potential for emergence of diseases. Emerging Infectious Diseases, 1, Unnumbered.
- Baird, J. K. (2004). Chloroquine resistance in Plasmodium vivax. Antimicrobial Agents and Chemotherapy, 48,4075–4083.
- Baird, J. K., Leksana, B., Masbar, S., Fryauff, D. J., Sutanihardja, M. A., Suradi, Wignall, F. S. & Hoffman, S. L. (1997a). Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recur-rence and whole blood levels. American Journal of Tropical Medicine and Hygiene, 56, 621-626.
- Baird, J. K., Wiady, I., Fryauff, D. J., Sutanihardja, M. A., Leksana, B., Widjaya, H., Kysdarmanto & Subianto, B. (1997b). In vivo resistance to chlor-oquine by Plasmodium vivax and Plasmodium falci-parum at Nabire, Irian Jaya, Indonesia. American Journal of Tropical Medicine and Hygiene, 56, 627-631.
- Berliner, R. W., Earle Jr, D. P., Taggart, J. V., Zubrod, C. G., Welch, W. J., Conan, N. J., Bauman, E., Scudder, S.T. & Shannon, J. A. (1948). Studies on the chemotherapy of the human malarias. VI. The physiological disposition, antimalarial activity, and toxicity of several derivatives of 4-aminoquinoline. Journal of Clinical Investigation, 27,98-107.
- Kurcer, M. A., Simsek, Z., Zeyrek, F. Y., Atay, S., celik, H., Kat, I. & Topluoglu, S. (2004). Efficacy of chloroquine in the treatment of Plasmodium vivax malaria in Turkey. Annals of Tropical Medicine and Parasitology, 98, 447-451.
- Lemeshow, S. & Taber, S. (1991). Lot quality assurance sampling: single- and double-sampling plans. World Health Statistics Quarterly, 44,115–129.
- Phillips, R. S. (2001). Current status of malaria and potential for control. Clinical Microbiology Reviews, 14, 208–226.
- Rieckmann, K. H., Davis, D. R. & Hutton, D. C. (1989). Plasmodium vivax resistant to chloroquine? Lancet, II, 1183-1184.
- Ruebush, T. K., Zegarra, J., Cairo, J., Andersen, E. M., Green, M., Pillai, D. R., Marquifio, W., Huilca, M., Arévalo, E., Garcia, C., Solary, L. & Kain, K. C. (2003). Chloroquine-resistant Plasmodium vivax malaria in Peru. American Journal of Tropical Medicine and Hygiene, 69, 548–552.
- Soto, J., Toledo, J., Gutierrez, P., Luzz, M., Llinas, N., Cedeno, N., Dunne, M. & Berman, J. (1999). Chloroquine sensitivity of Plasmodium vivax in Thailand. Annals of Tropical Medicine and Parasitology, 93, 225–230.
- Soto, J., Toledo, J., Gutierrez, P., Luzz, M., Llinas, N., Cedefio, N., Dunne, M. & Berman, J. (2001). Plasmodium vivax clinically resistant to chloroquine in Colombia. American Journal of Tropical Medicine and Hygiene, 65,90–93.
- Sumawinata, I. W., Bernadeta, Leksana, B., Sutami-hardja, A., Purnomo, Subianto, B., Sekartuti, Fryauff, D. J. & Baird, J. K. (2003). Very high risk of therapeutic failure with chloroquine for uncompli-cated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. American Journal of Tropical Medicine and Hygiene, 68, 416-420.
- Tabuk, T. C. & Ulger, S. (2000). The malaria situation in Turkey. Meditsinskaya Parazitologiya i Parazitarnye Bolezni, April—June, 26–27.
- Whitby, M. (1997). Drug resistant Plasmodium vivax malaria. Journal of Antimicrobial Chemotherapy, 40, 749–752.
- World Health Organization (1994). Antimalarial Drug Policies: Data Requirements, Treatment of Uncomplicated Malaria and Management of Malaria in Pregnancy. Document WHO/MAL/94. 1070. Geneva: WHO.
- World Health Organization (2000). WHO Expert Committee on Malaria: Twentieth Report. Technical Report Series No. 892. Geneva: WHO.
- World Health Organization (2002). A General Guide for the Assessment of Therapeutic Efficacy of Chloroquine for Vivax Malaria (Version 3). Geneva: WHO.